Basque Health Service
61
1
2
34
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Moderate Risk
Score: 35/100
4.9%
3 terminated/withdrawn out of 61 trials
91.9%
+5.4% vs industry average
25%
15 trials in Phase 3/4
3%
1 of 34 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (61)
Reduction of Low-value Prescribing Through Audit and Feedback
Role: lead
Asthma Crisis in Paediatrics: Impact of a Care Pathway in Primary and Hospital Care
Role: lead
De-implementation of Low-value Pharmacological Prescriptions
Role: lead
A Digital Home-Based Physiotherapy Program for Active Aging
Role: collaborator
BIZI ORAIN: Exercise for All People With Cancer
Role: lead
Effect of a Group Intervention Program Based on Acceptance and Mindfulness on the Physical and Emotional Well-being of Overweight and Obese Individuals
Role: collaborator
EfiKroniK Research Program: Physical Exercise for People With Chronic Pathologies
Role: lead
Health Promotion Community-based Intervention Among Elderly People Through Self-managed MAHA Mobile App.
Role: collaborator
Dexmedetomidine Versus Standard Clinical Practice During Non Invasive Mechanical Ventilation
Role: lead
Stimulation and Validation of the Pupillary Dilation for the Detection of Pain in Analgosedated Patients Under Mechanically Ventilation in Intensive Care Unit
Role: lead
Effectiveness of Musicotherapy in Weaning From Mechanical Ventilation
Role: lead
Rapid Maxillary Expansion for Residual Pediatric
Role: lead
The SEHNeCa Supervised Exercise Project
Role: lead
EMAehealth Web Tool for Pregnancy and Puerperium: Effectiveness
Role: collaborator
Clinical Applicability of the Device Belk in the Rehabilitation Process
Role: lead
Safety and Effectiveness of Drug up Titration by Nurses Specialized in Heart Failure (HF) Patients
Role: collaborator
Optimizing the Primary Prevention of Type-2 Diabetes in Primary Health Care
Role: lead
PRP ULCERAS: Clinical Trial Phase III
Role: lead
COGNITIVE BEHAVIORAL THERAPY PROGRAM TO FIRST-EPISODE PSYCHOSIS PATIENTS AND CANNABIS ABUSE
Role: lead
Treatment With a Scheme With Low Doses of Bortezomib / Melphalan / Prednisone (MPV) in Patients With Multiple Myeloma
Role: lead